Kristen Fortney
At a glance: Kristen Fortney is CEO at BioAge Labs (BIOA). Their latest SEC Form 4, filed Jan 15, 2026, reported a sale of $4.2M. On file: 0 purchase lines ($0) and 1 sale line ($4.2M).
Disclosed holdings: about $4.3M of BIOA stock: 976,949 shares reported on their latest Form 4 (filed Jan 15, 2026), valued at the Nov 20, 2026 close of $4.36. This counts only BIOA shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
CEO at BioAge Labs, Inc. (BIOA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jan 15SEC | BIOABioAge Labs, Inc. | Sell Plan | 233,107976,949 held (−19%) | $18.12 | $4.2M | -75.9% |
- Sell
CEO Kristen Fortney sold $4.2M of BIOA at $18.12 — pre-scheduled 10b5-1 plan sale.
Follow Kristen Fortney
Get one email when Kristen Fortney files a new purchase or sale. Free.
At most one email a day about Kristen Fortney, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.